Suven Life Sciences

BSE : 530239 | NSE : SUVEN

Industry : Pharma Research | ISIN : INE495B01038 | FreeFloat : 40.00% | FnO : No | LotSize : N/A


Intellectual Capital (IC)-707.15
Net Worth (NW)49.82
Intrinsic Worth (IW)-657.33
Market Cap (MC)1,188.18
Economic Value Added-22.84
Discount Rate%
Liquidity Premium%
Knowledge Basis (IC/IW)-107.58%
IC Gross Margin (EBITDA/IC)13.48%
IC Net Margin (NPT/IC)17.18%
Knowledge Turnover (Sales/IC)-0.02
Market to Intrinsic Value (MC/IW)-1.81

As OfIntrinsic ValueMarket Price
30 Sep 2021Rs. -51.64Rs. 93.35
6 Dec 2021 ---- Rs. 89.75
-0.90     -1.00%
Fundamental - medium termTechnical - near termCombined outlook
EVA > 0 : NoSell10 DMA : Rs. 91.11SellStrong Sell
KB > 50% : No50 DMA : Rs. 100.68
0 < M2IV < 1 : NoVol-Price trend : Falling

Question 3 - Is this stock undervalued?


Question 2 - Does this business have significant knowledge assets?


Question 1 - Is this business generating enough profits to cover its cost of capital?

* EVA is a registered trademark of Stern Stewart and Co.

Quarterly Results (Rs. Cr)
Quarter
Type*
Sales
Income
EBITDA
EBIT
PBT
PAT
NPT
Dec-18
S
2.11
8.85
-19.76
-20.75
-14.01
-14.40
-14.40
Mar-19
C
2.38
8.17
-42.41
-43.21
-43.50
-39.43
0.07
Jun-19
C
1.59
4.39
-30.87
-31.70
-40.05
-26.04
-26.15
Sep-19
C
1.39
3.77
-21.08
-22.50
-20.22
-19.81
-19.81
Dec-19
C
2.77
8.63
-27.66
-28.52
-22.77
-22.81
-22.81
Mar-20
C
8.66
11.66
-22.07
-23.13
-23.36
-25.56
-25.75
Jun-20
C
1.43
3.96
-11.67
-12.73
-12.96
-10.49
-10.49
Sep-20
C
8.98
11.26
-15.32
-16.39
-16.65
-15.66
-15.66
Dec-20
C
1.51
3.14
-24.98
-26.12
-26.30
-24.39
-24.39
Mar-21
C
1.56
2.88
-20.26
-21.32
-21.57
-21.61
-21.61
Jun-21
C
2.01
6.56
-38.02
-39.06
-39.21
-39.21
-39.21
Sep-21
C
1.18
1.69
-27.11
-28.15
-28.30
-28.30
-28.30
* C - Consolidated, S - Standalone